| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2004 | CN1483412A Application of Chinese aralis extract in preparation of medicine for treating dysmenorrhea and analgesia |
| 03/24/2004 | CN1483411A Licorzinc solution composition, preparation process thereof and licorzinc preparation |
| 03/24/2004 | CN1483410A Medicinal complsition containing vitamin B 1, preparation process and use thereof |
| 03/24/2004 | CN1483409A Buspirong hydrochloride transdemal absorption preparation |
| 03/24/2004 | CN1483408A Kecuocryptone gel and preparation process thereof |
| 03/24/2004 | CN1483407A Medicinal composition containing rotundine for anayesia and giving up drug-taking |
| 03/24/2004 | CN1483406A Maltilate emulsion and preparation proless thereof |
| 03/24/2004 | CN1483405A Aqueous injection of curcuma oil extract and preparation process and use |
| 03/24/2004 | CN1483404A Broad-spectrum antivenerenl external used medicine |
| 03/24/2004 | CN1483403A Liquid soft capsule containing brufen and pseudoephedrine hydrochloride |
| 03/24/2004 | CN1483401A Slow-released preparation |
| 03/24/2004 | CN1483327A Health care food containing dihydromyricetin and myricetin composition |
| 03/24/2004 | CN1142939C Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 03/24/2004 | CN1142937C Antibacterial cephalosporins |
| 03/24/2004 | CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof |
| 03/24/2004 | CN1142934C Metallocorrinoids as biologically compatible carriers of pharmocological agents |
| 03/24/2004 | CN1142933C Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical composition thereof |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/24/2004 | CN1142927C Chalcone coumarins |
| 03/24/2004 | CN1142926C Method for preparing citralopram |
| 03/24/2004 | CN1142923C 12,13-modified epothilone derivatives |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142918C Carboxylic acid derivs, their preparation and their use |
| 03/24/2004 | CN1142916C Dopamine D1 receptor agonist compounds |
| 03/24/2004 | CN1142913C Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142911C Compounds with growth hormone releasing properties |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/24/2004 | CN1142909C Indole derivatives with antiviral activity |
| 03/24/2004 | CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof |
| 03/24/2004 | CN1142902C Alk (En)yl dicarboxylic acid bisesters, their use and method for preparing them |
| 03/24/2004 | CN1142794C Photostable aqueous solution containing benzyl alcohol derivatives |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/24/2004 | CN1142792C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
| 03/24/2004 | CN1142791C Gel formulations containing growth factors |
| 03/24/2004 | CN1142790C Endoparasiticial composition |
| 03/24/2004 | CN1142788C Chinese medicine preparation for treating infant pulmonitis and dyspneic cough |
| 03/24/2004 | CN1142784C Process for preparing protein extracts |
| 03/24/2004 | CN1142783C Medicine for treating high-risk impaired clucose tolerance |
| 03/24/2004 | CN1142782C Dexamethasone gel |
| 03/24/2004 | CN1142781C Use of 9-deoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'- interphenylene)-13,14-dihydro-prostaglandin F, to treat peripheral vascular disease |
| 03/24/2004 | CN1142780C Pharmaceutical compositions |
| 03/24/2004 | CN1142778C Use of thiazolium compounds for preventing and preventing the formation of advanced glycosylation endproducts |
| 03/24/2004 | CN1142777C Use of oxazolidinone derivative for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 03/24/2004 | CN1142776C Antibacterial agents and cosmetics and clothes containing the same |
| 03/24/2004 | CN1142775C Use of adamantan derivative for treating diseases of inner ear |
| 03/24/2004 | CN1142774C Method and pharmaceutical preparations for reducing the activity of cells |
| 03/24/2004 | CN1142773C Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof |
| 03/24/2004 | CN1142770C Process for production of powdered pulmoney surfactant preparations |
| 03/24/2004 | CN1142753C Skin patches for providing testosterone |
| 03/24/2004 | CN1142724C Two-stage preparation |
| 03/23/2004 | WO2004080458A1 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 03/23/2004 | US6711436 Compositions, apparatus and methods for facilitating surgical procedures |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710195 Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions |
| 03/23/2004 | US6710191 9β-hydroxytetracyclic taxanes |
| 03/23/2004 | US6710184 Crystalline solids of carvedilol and processes for their preparation |
| 03/23/2004 | US6710179 Compounds with analgesic effect |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710090 Inhibitory or blocking agents of molecular generating and/or inducing functions |
| 03/23/2004 | US6710088 Inorganic ion receptor-active compounds |
| 03/23/2004 | US6710087 For therapy and prophylaxis of disorders that are ameliorated by the inhibition of neuronal monoamine uptake in mammals; disorders including erectile dysfunction, affective disorders, obesity, cerebral function disorders, pain |
| 03/23/2004 | US6710084 Administering to the subject an effective anti-inflammatory amount of a lipoxin analog |
| 03/23/2004 | US6710083 Method of treating palmar and plantar fibromatosis |
| 03/23/2004 | US6710081 One or more compounds selected from prostaglandin derivatives or cyclodextrin clathrate compounds |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710077 Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of HIV to uninfected cells and contraceptive compositions comprising the said derivatives |
| 03/23/2004 | US6710076 Hydroxy acids with kojic acid; topical treatment for hyperpigmentation, photodamage, aging, acne |
| 03/23/2004 | US6710075 Compounds having a cyclopentabenzofuran core shown to exhibit potent cytotoxic and cytostatic effects on cancer cell growth and viability |
| 03/23/2004 | US6710074 Compound having antimalarial activity |
| 03/23/2004 | US6710073 Drugs that induce long term potentiation (ltp) and enhance cognitive function in mammals |
| 03/23/2004 | US6710072 Vision defects |
| 03/23/2004 | US6710071 Such as ((3-4-(difluoro(phenyl)methyl)phenoxyl-3-phenylpropyl)methylamino)acetic acid; for the enhancement of cognition and the treatment of scizophrenia and other psychoses |
| 03/23/2004 | US6710070 Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710068 Phenylsulfonylinodles useful for the treatment of hiv in humans and other host animals |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710066 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins |
| 03/23/2004 | US6710065 Benzimidazole derivatives and their use for the treatment of cancer or a viral infection |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710059 Methods of treating and/or suppressing weight gain |
| 03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
| 03/23/2004 | US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710052 Anticancer agents |
| 03/23/2004 | US6710051 Screening method |
| 03/23/2004 | US6710050 Pharmaceutical composition and the process for its preparation |
| 03/23/2004 | US6710049 Fungicides for aids, diabetic patients |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710047 Phthalazines with angiogenesis inhibiting activity |
| 03/23/2004 | US6710046 Pharmaceutical composition for modulating immunity |
| 03/23/2004 | US6710045 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (IV) |
| 03/23/2004 | US6710044 Technical field |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/23/2004 | US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/23/2004 | US6710041 Pyrrolo[2,1-B][3,1] benzothiazepines and their use for the preparation of medicaments with antipsychotic activity |
| 03/23/2004 | US6710039 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharamceutical compositions containing these compounds |
| 03/23/2004 | US6710033 Treating with anti-chlamydial agents to improve or sustain neurological function |
| 03/23/2004 | US6710029 Dehydrodidemnin B |
| 03/23/2004 | US6710028 Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron |